Bulletin 21

October 2005

Greetings again! A short Bulletin this time, but it contains important information supplied by Ken Manley, the trustee who runs our research group. The CHROME database continues to be enlarged and updated, and these notes will show that good use is being made of it. Otherwise there is nothing to report.

ME Alliance
The ME Alliance campaign for early diagnosis, launched in ME Awareness week in May and supported by CHROME, went very well, receiving good publicity and an opportunity to raise the awareness of many problems with the medical community and with government. We still have a few copies of the Alliance report for any who would like to see it.

CHROME has chosen to become an Associate member of the Alliance as we are keen to continue to support the Alliance but do not have resources comparable to other member charities to become actively involved in campaigning.

PRIME
CHROME is continuing productive discussions with the PRIME (Partnership for Research in CFS and ME) project to explore how the copious and unique data provided by our participants might be exploited by PRIME.

Analyses of CHROME data
We have received the first, very thorough and original, draft of a report by Vladimir Koliadin, a Ukrainian statistician who is a friend of a CHROME trustee. The report provides, inter alia, novel ways of visualising our very complex data with graphical techniques. We are discussing with Mr Koliadin how the report might be developed further.

We also have the report of an MSc student, now resident in South Africa and a “distant student” of the London School of Hygiene and Tropical Medicine, analysing the effect of exercise on people severely affected by ME. The report is, of course, not for publication but could stimulate further investigation of this controversial area of treatment.

“Any other comments”
Following the item in Bulletin 20 we are very grateful that we have a volunteer (a doctor with ME) to produce an article,  developed from some of the detailed and often very moving information provided by participants and their carers in the “any other comments” section of questionnaires. This article will be aimed at the medical profession. Comments and additional offers to help work on our data are still welcome!


CHROME Home Page